Research Article
Epicatechin Used in the Treatment of Intestinal Inflammatory Disease: An Analysis by Experimental Models
Table 6
Immunohistochemical quantifications of cyclooxygenase-2 (COX-2) and poliferating cell nuclear antigen (PCNA) and immunoblotting of epidermal growth factor (EGF) and inducible nitric oxide sintase (iNOS) in the colon of the animals submitted to the chronic colitis model.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Results expressed as mean ± E.P.M. ANOVA-Dunnet, *P < 0.05 comparing to the TNBS group, #P < 0.05 comparing to not relapsed TNBS control. n = 4–7. EC 10: Epicatechin, dose 10 mg/kg. RU: random units. |